Memphasys (ASX:MEM) confirmed the RoXsta Mega Cell High-Throughput Assay device was capable of simultaneously processing 96 samples in less than an hour during recent trials, according to a Thursday filing with the Australian bourse.
The diagnostic device has been developed for rapid and high-capacity testing of reactive oxygen species levels in biological fluids, the filing said.
The device has been utilized in various studies, including assessing oxidative stress in cattle and assessing antioxidant levels in professional footballers, per the filing.